rivastigmine has been researched along with Lewy Body Disease in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 43 (78.18) | 29.6817 |
| 2010's | 11 (20.00) | 24.3611 |
| 2020's | 1 (1.82) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, PG; Rajkumar, AP; Storr, NJ; Watts, KE | 1 |
| Beireis, LA; Burgett, RN; Farley, TM | 1 |
| Grossberg, GT; Jeyakumar, S; Khoury, R; Noufi, P | 1 |
| Braund, V; DesLauris, C; Leikin, JB | 1 |
| Shoji, M | 1 |
| Kawano, H; Maemura, K; Muto, S; Nakatomi, D; Yamasa, T | 1 |
| Chouliaras, L; Hickey, L; Nour, JM | 1 |
| Graham, K; Josif, S | 1 |
| Ballard, C; Emre, M; He, Y; Lane, R; Leverenz, JB; Morris, C | 1 |
| McKeith, I | 1 |
| Hasselbalch, SG; Kampmann, JP | 1 |
| Berendse, HW; Bosboom, JL; Stam, CJ; Stoffers, D; Wolters, ECh | 1 |
| Adler, CH; Almaraz, AC; Caselli, RJ; Caviness, JN; Demaerschalk, BM; Driver-Dunckley, ED; Wellik, KE; Wingerchuk, DM; Woodruff, BK | 1 |
| Dautzenberg, PL; Feitsma, MT; van Laar, T | 1 |
| Manni, R; Ossola, M; Pacchetti, C; Rustioni, V; Terzaghi, M; Zangaglia, R | 1 |
| Deuschl, G; Förstl, H; Mollenhauer, B; Oertel, W; Storch, A; Trenkwalder, C | 1 |
| Landau, R | 1 |
| Bedouch, P; Besson, G; Casez, O; Chapuis, C; Lagrange, E | 1 |
| Fox, C; Maidment, I; McShane, R; Rolinski, M | 1 |
| Hoefnagels, WH; Horstink, MW; Scheepmaker, AJ; Strijks, FE | 1 |
| Dhondt, AD; Moerkens, RM | 1 |
| Mol, JA | 1 |
| Burns, A; Pettit, T; Wild, R | 1 |
| Kaufer, DI | 2 |
| de Brito-Marques, PR; de Mello, RV; Montenegro, L | 1 |
| Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA | 1 |
| García-Borreguero, D; Serrano, C | 1 |
| Press, DZ | 1 |
| Simard, M; van Reekum, R | 1 |
| Boeve, BF | 1 |
| Alwahhabi, FK | 1 |
| Driguès, N; Sagi, Y; Youdim, MB | 1 |
| Bergman, H; Bullock, R; Lane, R; Nagel, J; Rapatz, G; Touchon, J | 1 |
| Cummings, JL; Ringman, JM | 1 |
| Ballard, C; Barone, P; Ferrara, R; Lane, R; Tekin, S | 1 |
| Johannsen, P | 1 |
| Bhasin, M; Edwards, K; McKeith, I; Rowan, E | 1 |
| Ballard, CG; Chalmers, KA; Love, S; McKeith, IG; O'Brien, JT; Perry, EK; Todd, C; Wilcock, G | 1 |
| Damier, P; Meyniel, C | 1 |
| Cummings, JL; Emre, M; Lane, RM | 1 |
| Anghelescu, I; Heuser, I | 1 |
| Clerici, F; Elia, A; Maggiore, L; Mariani, C; Pomati, S; Ratti, PL | 1 |
| Aguglia, E; Onor, ML; Trevisiol, M | 1 |
| Landmark, K; Reikvam, A | 1 |
| Byrne, EJ; Grace, JB; McKeith, IG; Perry, EK; Stevens, T; Walker, Z; Wilkinson, D | 1 |
| Grace, JB; McKeith, IG; Walker, MP | 1 |
| Anand, R; Cicin-Sain, A; Del Ser, T; Ferrara, R; McKeith, I; Spiegel, R | 1 |
| Cummings, JL | 1 |
| Anand, R; Cicin-Sain, A; Del Ser, T; Emre, M; Ferrara, R; McKeith, I; Spano, P; Spiegel, R; Wesnes, K | 1 |
| Hogan, DB; Patterson, C | 1 |
| Butler, S; Byrne, EJ; Daniel, S; Grace, J; McKeith, IG; Shankar, KK; Stevens, T; Waite, J; Walker, Z; Wilkinson, D; Woolford, J | 1 |
| Byrne, EJ; Collins, CC; Maclean, LE | 1 |
| Anand, R; Cicin-Sain, A; Del Ser, T; Emre, M; Ferrara, R; McKeith, IG; Spano, PF; Spiegel, R; Wesnes, KA | 1 |
20 review(s) available for rivastigmine and Lewy Body Disease
| Article | Year |
|---|---|
Systematic review of pharmacological interventions for people with Lewy body dementia.
Topics: Alzheimer Disease; Dementia; Humans; Lewy Body Disease; Parkinson Disease; Rivastigmine | 2023 |
Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.
Topics: Acetylcholine; Aged; Cholinesterase Inhibitors; Frontotemporal Lobar Degeneration; Humans; Lewy Body Disease; Rivastigmine | 2019 |
[Programs for continuing medical education: a session; 3. Dementia: diagnosis and therapy].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cholinesterase Inhibitors; Cognitive Dysfunction; Dementia; Disease Progression; Donepezil; Education, Medical, Continuing; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Peptide Fragments; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Reference Standards; Rivastigmine; tau Proteins; Tomography, Emission-Computed, Single-Photon | 2014 |
Diagnosis and treatment of dementia with Lewy bodies.
Topics: Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Phenylcarbamates; Piperidines; Prognosis; Rivastigmine; Tacrine | 2008 |
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia.
Topics: Acetylcholine; Administration, Oral; Aged; Brain; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Placebos; Rivastigmine; Treatment Outcome | 2009 |
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.
Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2010 |
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Topics: Cholinesterase Inhibitors; Cognition Disorders; Dementia; Donepezil; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2012 |
Cholinesterase inhibitors for dementia with Lewy bodies.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Humans; Lewy Body Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine | 2003 |
Fluctuations in cognition and alertness in Parkinson's disease and dementia.
Topics: Awareness; Central Nervous System Stimulants; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Double-Blind Method; Humans; Lewy Body Disease; Melatonin; Multicenter Studies as Topic; Parkinson Disease; Phenylcarbamates; Phototherapy; Randomized Controlled Trials as Topic; Rivastigmine | 2004 |
The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
Topics: Aged; Basal Ganglia Diseases; Behavior; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Cognition Disorders; Donepezil; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Tacrine | 2004 |
Current and emerging pharmacological treatment options for dementia.
Topics: Acetylcholine; Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine; Tacrine | 2006 |
Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Double-Blind Method; Female; Heart Diseases; Humans; Lewy Body Disease; Male; Middle Aged; Multicenter Studies as Topic; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine | 2006 |
[Medical treatment of Alzheimer's disease].
Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Dementia, Vascular; Disease Progression; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Memantine; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome | 2006 |
[Lewy body dementia and Parkinson disease dementia].
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cholinesterase Inhibitors; Clozapine; Dementia; Diagnosis, Differential; Disease Progression; Dopamine Agents; Humans; Iatrogenic Disease; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Parkinsonian Disorders; Phenylcarbamates; Psychotropic Drugs; Rivastigmine; Serotonin Antagonists | 2007 |
Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
Topics: Activities of Daily Living; Alzheimer Disease; Double-Blind Method; Hallucinations; Humans; Lewy Body Disease; Mental Status Schedule; Multicenter Studies as Topic; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome | 2007 |
[Acetylcholinesterase inhibitors for dementia--an update].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Multicenter Studies as Topic; Neuroprotective Agents; Nootropic Agents; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Time Factors | 2007 |
Rivastigmine in the treatment of Alzheimer's disease: an update.
Topics: Alzheimer Disease; Behavior; Clinical Trials as Topic; Humans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Rivastigmine | 2007 |
[Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Donepezil; Evidence-Based Medicine; Galantamine; Humans; Indans; Lewy Body Disease; Phenylcarbamates; Piperidines; Rivastigmine; Time Factors; Treatment Outcome | 2008 |
Brief review: rivastigmine, a second cholinesterase inhibitor.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Randomized Controlled Trials as Topic; Rivastigmine | 2001 |
Understanding changes in cholinergic function: implications for treating dementia.
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinergic Fibers; Cholinesterase Inhibitors; Dementia; Humans; Lewy Body Disease; Mental Disorders; Neuroprotective Agents; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Treatment Outcome | 2002 |
6 trial(s) available for rivastigmine and Lewy Body Disease
| Article | Year |
|---|---|
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Topics: Aged; Attention; Carbamates; Disease Progression; Double-Blind Method; Female; Hallucinations; Humans; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Nootropic Agents; Phenylcarbamates; Prospective Studies; Reaction Time; Risk Factors; Rivastigmine | 2004 |
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Drug Tolerance; Female; Humans; Lewy Body Disease; Male; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2000 |
Dementia with lewy bodies: findings from an international multicentre study.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Female; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Neuropsychological Tests; Phenylcarbamates; Psychometrics; Reproducibility of Results; Rivastigmine | 2000 |
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Double-Blind Method; Female; Humans; Lewy Body Disease; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2000 |
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body Disease; Male; Middle Aged; Neuroprotective Agents; Parkinsonian Disorders; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2001 |
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.
Topics: Aged; Carbamates; Diagnosis, Computer-Assisted; Double-Blind Method; Female; Follow-Up Studies; Humans; Lewy Body Disease; Male; Neurology; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Prospective Studies; Rivastigmine; Treatment Outcome | 2002 |
29 other study(ies) available for rivastigmine and Lewy Body Disease
| Article | Year |
|---|---|
Acute treatment of psychotic symptoms in a newly diagnosed Lewy body dementia patient with an accelerated titration schedule of rivastigmine and de-escalation of antipsychotics.
Topics: Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Hallucinations; Humans; Lewy Body Disease; Male; Psychotic Disorders; Quetiapine Fumarate; Rivastigmine | 2019 |
Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
Topics: Aged; Bradycardia; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Humans; Indans; Lewy Body Disease; Male; Miosis; Parkinson Disease; Phenylcarbamates; Piperidines; Rivastigmine | 2014 |
Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Comorbidity; Electrocardiography; Female; Heart Failure; Humans; Lewy Body Disease; Phenylcarbamates; Rivastigmine; Sinus Arrest, Cardiac | 2015 |
High dose rivastigmine in the symptom management of Lewy body dementia.
Topics: Aged; Cholinesterase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Humans; Lewy Body Disease; Male; Phenylcarbamates; Quality of Life; Rivastigmine; Treatment Outcome | 2016 |
BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
Topics: Aged; Apolipoprotein E4; Butyrylcholinesterase; Cognition Disorders; Female; Gene Frequency; Genotype; Humans; Hyperhomocysteinemia; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychomotor Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index | 2009 |
Top cited papers in International Psychogeriatrics: 1. Long-term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Topics: Aged; Cholinesterase Inhibitors; Clinical Trials as Topic; History, 21st Century; Humans; Journal Impact Factor; Lewy Body Disease; Long-Term Care; Periodicals as Topic; Phenylcarbamates; Rivastigmine | 2009 |
[Treatment of degenerative dementia disorders--who should be treated?].
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Dopamine Agents; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lewy Body Disease; Memantine; Middle Aged; Neuroprotective Agents; Parkinson Disease; Patient Selection; Phenylcarbamates; Rivastigmine | 2009 |
Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.
Topics: Acetylcholine; Aged; Aged, 80 and over; Biological Clocks; Brain Mapping; Cerebral Cortex; Cholinesterase Inhibitors; Evoked Potentials; Humans; Lewy Body Disease; Magnetoencephalography; Phenylcarbamates; Rivastigmine; Signal Processing, Computer-Assisted; Synaptic Transmission; Treatment Outcome | 2009 |
[The possible value of diagnosing MCI-DLB and treatment options].
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Early Diagnosis; Female; Humans; Lewy Body Disease; Phenylcarbamates; Prognosis; Rivastigmine; Treatment Outcome | 2009 |
Agrypnia with nocturnal confusional behaviors in dementia with Lewy bodies: immediate efficacy of rivastigmine.
Topics: Aged; Confusion; Female; Humans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Sleep Initiation and Maintenance Disorders | 2010 |
Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory.
Topics: Aged; Brain; Cholinesterase Inhibitors; Cross-Sectional Studies; Dementia; Diagnosis, Differential; Diagnostic Imaging; Donepezil; Early Diagnosis; Evidence-Based Medicine; Humans; Indans; Lewy Body Disease; Mental Disorders; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2011 |
Hallucinations treated with rivastigmine in Creutzfeldt-Jakob disease.
Topics: Aged; Cholinesterase Inhibitors; Creutzfeldt-Jakob Syndrome; Female; Hallucinations; Humans; Lewy Body Disease; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2012 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Cholinesterase Inhibitors; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Male; Neuroprotective Agents; Olanzapine; Phenylcarbamates; Pirenzepine; Risperidone; Rivastigmine; Treatment Outcome | 2003 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Carbamates; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Treatment Outcome | 2003 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Carbamates; Cholinesterase Inhibitors; Hospitalization; Humans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Time Factors; Treatment Outcome | 2003 |
Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Brain; Carbamates; Cholinesterase Inhibitors; Diagnosis, Differential; Donepezil; Galantamine; Humans; Indans; Lewy Body Disease; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Treatment Outcome | 2004 |
Nightmares without atonia as an early symptom of diffuse Lewy bodies disease.
Topics: Aged; Atrophy; Carbamates; Cholinesterase Inhibitors; Dreams; Fatal Outcome; Humans; Immunohistochemistry; Lewy Body Disease; Magnetic Resonance Spectroscopy; Male; Neurons; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Substantia Nigra; Tomography, X-Ray Computed | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galantamine; Hallucinations; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Psychomotor Agitation; Rivastigmine; Social Behavior | 2004 |
Parkinson's disease dementia--a first step?
Topics: Antiparkinson Agents; Cholinesterase Inhibitors; Dementia; Disease Progression; Humans; Lewy Body Disease; Nausea; Parkinson Disease; Phenylcarbamates; Rivastigmine | 2004 |
Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease.
Topics: Cholinesterase Inhibitors; Dementia; Humans; Lewy Body Disease; Parkinson Disease; Phenylcarbamates; Rivastigmine | 2005 |
Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
Topics: Aged; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Lewy Body Disease; Neuroprotective Agents; Phenylcarbamates; Piperidines; Rivastigmine; Sweating | 2005 |
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocampus; Hyperkinesis; Indans; Levodopa; Lewy Body Disease; Male; Monoamine Oxidase Inhibitors; Motor Activity; Muscarinic Antagonists; Norepinephrine; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Serotonin; Time Factors; Tranylcypromine; Tryptophan | 2005 |
Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Double-Blind Method; Female; Humans; Indans; Lewy Body Disease; Male; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Retrospective Studies; Rivastigmine; Treatment Outcome | 2006 |
Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
Topics: Aged; Analysis of Variance; Cholinesterase Inhibitors; Clinical Trials as Topic; Data Interpretation, Statistical; Donepezil; Female; Galantamine; Humans; Indans; Lewy Body Disease; Male; Neuropsychological Tests; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Treatment Outcome | 2007 |
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Autopsy; Cerebral Cortex; Cholinesterase Inhibitors; Clinical Trials as Topic; Cohort Studies; Donepezil; Drug Evaluation; Female; Galantamine; Humans; Indans; Lewy Body Disease; Male; Middle Aged; Neuroprotective Agents; Phenylcarbamates; Piperidines; Prospective Studies; Rivastigmine; Tacrine; tau Proteins; Tauopathies | 2007 |
Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation.
Topics: Acetylcholine; Aged; Cholinesterase Inhibitors; Disease Progression; Humans; Lewy Body Disease; Male; Parkinsonian Disorders; Phenylcarbamates; Rivastigmine; Time Factors | 2007 |
A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Female; Humans; Lewy Body Disease; Male; Middle Aged; Phenylcarbamates; Polysomnography; Rivastigmine; Sleep Wake Disorders; Treatment Outcome | 2000 |
Cholinesterase inhibitors: expanding applications.
Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Lewy Body Disease; Phenylcarbamates; Rivastigmine | 2000 |
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body Disease; Male; Middle Aged; Phenylcarbamates; Psychomotor Agitation; Rivastigmine; Sleep; Treatment Outcome | 2001 |